Dan Lipsker
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Dan Lipsker has a total of 315 co-authors. Here are the top co-authors by number of shared publications:
B Cribier
12 shared publicationsB. Cribier
Clinique dermatologique, Université de Strasbourg et Hôpitaux Universitaires de Strasbourg, 1 place de l'Hôpital, 67091 Strasbourg, France
11 shared publicationsE Grosshans
11 shared publications- Cedric Lenormand
Department of Dermatology, University Hospital of Strasbourg, Strasbourg, France; University of Strasbourg, Medical Faculty, UR3073 - PHAVI, Strasbourg, France
7 shared publications E Heid
7 shared publicationsCédric Lenormand
Dermatology Clinic, Strasbourg University Hospitals, Strasbourg, France; Faculté de Médecine, Université de Strasbourg, Strasbourg, France
6 shared publications
Latest Publications
- Open Access
- 9 March 2026
- Published by Wiley in JEADV Clinical Practice
- Vol. 5 (3) , 956-958
Post‐Radiation Granuloma Annulare: A Series of Three Cases
We report typical cases of biopsy confirmed granuloma annulare occurring on irradiated skin in the context of breast cancer in three women in their seventies. The lesions appeared immediately after start of irradiation in one patient, 4 and 15 months after the end of radiation treatment in the other two. The lesions eventually spread elsewhere on the body in two patients. Similar to morphea, which is a well‐known side effect of irradiation, we believe that radiotherapy can induce tissue damage, leading to dermal inflammation ultimately responsible for the emergence of granuloma annulare.
- 9 March 2026
- Published by Wiley in JEADV Clinical Practice
- Vol. 5 (3) , 956-958
Open AccessPost‐Radiation Granuloma Annulare: A Series of Three Cases
We report typical cases of biopsy confirmed granuloma annulare occurring on irradiated skin in the context of breast cancer in three women in their seventies. The lesions appeared immediately after start of irradiation in one patient, 4 and 15 months after the end of radiation treatment in the other two. The lesions eventually spread elsewhere on the body in two patients. Similar to morphea, which is a well‐known side effect of irradiation, we believe that radiotherapy can induce tissue damage, leading to dermal inflammation ultimately responsible for the emergence of granuloma annulare.
- Open Access
- 25 October 2025
- Published by Wiley in Journal of the European Academy of Dermatology and Venereology
- Vol. 39 (11) , 1878-1880
Pioneers in Dermatology and Venereology: An interview with Professor Dan Lipsker
- 25 October 2025
- Published by Wiley in Journal of the European Academy of Dermatology and Venereology
- Vol. 39 (11) , 1878-1880
Open AccessPioneers in Dermatology and Venereology: An interview with Professor Dan Lipsker
- Open Access
- 25 April 2025
- Published by Wiley in Journal of the European Academy of Dermatology and Venereology
- Vol. 39 (5) , 891-892
Clonal disorders of clinical significance. A concept with important therapeutic implications
- 25 April 2025
- Published by Wiley in Journal of the European Academy of Dermatology and Venereology
- Vol. 39 (5) , 891-892
Open AccessClonal disorders of clinical significance. A concept with important therapeutic implications
- Open Access
- 31 May 2024
- Published by MDPI AG in Biomolecules
- Vol. 14 (6) , 646
Schnitzler Syndrome: Insights into Its Pathogenesis, Clinical Manifestations, and Current Management
Schnitzler syndrome is a rare disorder characterized by a chronic urticarial rash associated with immunoglobulin M (IgM) monoclonal gammopathy. Schnitzler syndrome shares strong clinicopathologic similarities with monogenic IL-1-mediated autoinflammatory disorders and is now considered an acquired adult-onset autoinflammatory disease. The spectacular effect of interleukin-1 inhibitors demonstrates the key role of this cytokine in the pathogenesis of the disease. However, the physiopathology of Schnitzler syndrome remains elusive, and the main question regarding the relationship between autoinflammatory features and monoclonal gammopathy is still unanswered. The purpose of this narrative review is to describe what is currently known about the pathogenesis of this peculiar disease, as well as to address its diagnosis and management.
- 31 May 2024
- Published by MDPI AG in Biomolecules
- Vol. 14 (6) , 646
Open AccessSchnitzler Syndrome: Insights into Its Pathogenesis, Clinical Manifestations, and Current Management
Schnitzler syndrome is a rare disorder characterized by a chronic urticarial rash associated with immunoglobulin M (IgM) monoclonal gammopathy. Schnitzler syndrome shares strong clinicopathologic similarities with monogenic IL-1-mediated autoinflammatory disorders and is now considered an acquired adult-onset autoinflammatory disease. The spectacular effect of interleukin-1 inhibitors demonstrates the key role of this cytokine in the pathogenesis of the disease. However, the physiopathology of Schnitzler syndrome remains elusive, and the main question regarding the relationship between autoinflammatory features and monoclonal gammopathy is still unanswered. The purpose of this narrative review is to describe what is currently known about the pathogenesis of this peculiar disease, as well as to address its diagnosis and management.
- 17 August 2023
- Published by Elsevier in Annales de Dermatologie et de Vénéréologie
- Vol. 150 (4) , 260-269
Non-scarring alopecia of lupus erythematosus: A comprehensive review
- 17 August 2023
- Published by Elsevier in Annales de Dermatologie et de Vénéréologie
- Vol. 150 (4) , 260-269
Non-scarring alopecia of lupus erythematosus: A comprehensive review
- 24 May 2023
- Published by Wiley in Journal of the European Academy of Dermatology and Venereology
- Vol. 37 (10)
Paradoxical joint and muscle pain in a patient treated with anifrolumab and belimumab
- 24 May 2023
- Published by Wiley in Journal of the European Academy of Dermatology and Venereology
- Vol. 37 (10)
Paradoxical joint and muscle pain in a patient treated with anifrolumab and belimumab
- 22 November 2022
- Published by Wiley in Journal of the European Academy of Dermatology and Venereology
- Vol. 37 (5) , E626-E627
Topical steroid‐induced visual disturbances related to central serous chorioretinopathy. A potentially serious complication of dermocorticoids
- 22 November 2022
- Published by Wiley in Journal of the European Academy of Dermatology and Venereology
- Vol. 37 (5) , E626-E627
Topical steroid‐induced visual disturbances related to central serous chorioretinopathy. A potentially serious complication of dermocorticoids
- Open Access
- 8 November 2022
- Published by American Society for Clinical Investigation in JCI Insight
- Vol. 7 (21)
Keratinocyte-derived cytokine TSLP promotes growth and metastasis of melanoma by regulating the tumor-associated immune microenvironment
Malignant melanoma is a major public health issue displaying frequent resistance to targeted therapy and immunotherapy. A major challenge lies in better understanding how melanoma cells evade immune elimination and how tumor growth and metastasis is facilitated by the tumor microenvironment. Here, we show that expression of the cytokine thymic stromal lymphopoietin (TSLP) by epidermal keratinocytes is induced by cutaneous melanoma in both mice and humans. Using genetically engineered models of melanoma and tumor cell grafting combined with TSLP-KO or overexpression, we defined a crosstalk between melanoma cells, keratinocytes, and immune cells in establishing a tumor-promoting microenvironment. Keratinocyte-derived TSLP is induced by signals derived from melanoma cells and subsequently acts via immune cells to promote melanoma progression and metastasis. Furthermore, we show that TSLP signals through TSLP receptor–expressing (TSLPR-expressing) DCs to play an unrecognized role in promoting GATA3 + Tregs expressing a gene signature including ST2, CCR8, ICOS, PD-1, CTLA-4, and OX40 and exhibiting a potent suppressive activity on CD8 + T cell proliferation and IFN-γ production. An analogous population of GATA3-expressing Tregs was also identified in human melanoma tumors. Our study provides insights into the role of TSLP in programming a protumoral immune microenvironment in cutaneous melanoma.
- 8 November 2022
- Published by American Society for Clinical Investigation in JCI Insight
- Vol. 7 (21)
Open AccessKeratinocyte-derived cytokine TSLP promotes growth and metastasis of melanoma by regulating the tumor-associated immune microenvironment
Malignant melanoma is a major public health issue displaying frequent resistance to targeted therapy and immunotherapy. A major challenge lies in better understanding how melanoma cells evade immune elimination and how tumor growth and metastasis is facilitated by the tumor microenvironment. Here, we show that expression of the cytokine thymic stromal lymphopoietin (TSLP) by epidermal keratinocytes is induced by cutaneous melanoma in both mice and humans. Using genetically engineered models of melanoma and tumor cell grafting combined with TSLP-KO or overexpression, we defined a crosstalk between melanoma cells, keratinocytes, and immune cells in establishing a tumor-promoting microenvironment. Keratinocyte-derived TSLP is induced by signals derived from melanoma cells and subsequently acts via immune cells to promote melanoma progression and metastasis. Furthermore, we show that TSLP signals through TSLP receptor–expressing (TSLPR-expressing) DCs to play an unrecognized role in promoting GATA3 + Tregs expressing a gene signature including ST2, CCR8, ICOS, PD-1, CTLA-4, and OX40 and exhibiting a potent suppressive activity on CD8 + T cell proliferation and IFN-γ production. An analogous population of GATA3-expressing Tregs was also identified in human melanoma tumors. Our study provides insights into the role of TSLP in programming a protumoral immune microenvironment in cutaneous melanoma.
- 17 October 2022
- Published by Wiley in Journal of the European Academy of Dermatology and Venereology
- Vol. 37 (2) , 436-442
Superficial (nodular) thrombophlebitis as a heterogeneous entity with distinctive clinico‐pathological aspects: Correlation with the underlying conditions
Background: Superficial (nodular) thrombophlebitis, referring to a thrombo‐inflammatory disorder of dermal‐subcutaneous veins, encompass a spectrum of nodular lesions often associated with inflammatory, infectious, neoplastic or thrombophilic diseases.Objective: We postulate that distinct clinico‐pathological features may correlate with the underlying conditions.Methods: We conducted a retrospective monocentric study of all patients seen in our dermatology department for a superficial thrombophlebitis, completed with a literature review. Clinical and pathological data were extracted from the patient files and articles.Results: A total of 108 cases of superficial thrombophlebitis was analysed. Forty‐five percent manifested as elongated nodules clearly evoking vascular involvement, while the other 55% were presenting as nodules or plaques. The elongated phenotype was strongly associated with malignancy or thrombophilia if a pure thrombosis was demonstrated histopathologically, while tuberculosis was the main underlying condition if a granulomatous vasculitis was present. Panniculitis‐like lesions were mainly corresponding to erythema‐nodosum‐like lesions of Behçet's disease, characterized by the distinctive feature of thrombotic veins with an associated leukocytoclastic vasculitis.Limitations: Retrospective design and risk of publication bias.Conclusion: Superficial (nodular) thrombophlebitis is a heterogeneous entity with a distinct clinico‐pathological presentation that strongly points to the nature of the underlying medical condition, thus guiding the medical workup.
- 17 October 2022
- Published by Wiley in Journal of the European Academy of Dermatology and Venereology
- Vol. 37 (2) , 436-442
Superficial (nodular) thrombophlebitis as a heterogeneous entity with distinctive clinico‐pathological aspects: Correlation with the underlying conditions
Background: Superficial (nodular) thrombophlebitis, referring to a thrombo‐inflammatory disorder of dermal‐subcutaneous veins, encompass a spectrum of nodular lesions often associated with inflammatory, infectious, neoplastic or thrombophilic diseases.Objective: We postulate that distinct clinico‐pathological features may correlate with the underlying conditions.Methods: We conducted a retrospective monocentric study of all patients seen in our dermatology department for a superficial thrombophlebitis, completed with a literature review. Clinical and pathological data were extracted from the patient files and articles.Results: A total of 108 cases of superficial thrombophlebitis was analysed. Forty‐five percent manifested as elongated nodules clearly evoking vascular involvement, while the other 55% were presenting as nodules or plaques. The elongated phenotype was strongly associated with malignancy or thrombophilia if a pure thrombosis was demonstrated histopathologically, while tuberculosis was the main underlying condition if a granulomatous vasculitis was present. Panniculitis‐like lesions were mainly corresponding to erythema‐nodosum‐like lesions of Behçet's disease, characterized by the distinctive feature of thrombotic veins with an associated leukocytoclastic vasculitis.Limitations: Retrospective design and risk of publication bias.Conclusion: Superficial (nodular) thrombophlebitis is a heterogeneous entity with a distinct clinico‐pathological presentation that strongly points to the nature of the underlying medical condition, thus guiding the medical workup.
- 7 October 2022
- Published by Wiley in Journal of the European Academy of Dermatology and Venereology
- Vol. 37 (2) , E189-E190
Dapsone in non‐bullous skin lesions of lupus erythematosus: A literature review
- 7 October 2022
- Published by Wiley in Journal of the European Academy of Dermatology and Venereology
- Vol. 37 (2) , E189-E190
Dapsone in non‐bullous skin lesions of lupus erythematosus: A literature review